Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Care
DOI: 10.2337/dc15-2782
Author: The FLAT-SUGAR Trial Investigators
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: glycemic variability, type 2 diabetes, GLP-1 receptor agonists, exenatide, rapid-acting insulin analogs, multiple daily insulin injections, cardiovascular risk, glycemic control, HbA1c, hypoglycemia, cardiac arrhythmias, body weight, cardiometabolic risk markers, serum amyloid A, alanine aminotransferase
Open Access status: closed
Funders: Bristol-Myers Squibb, AstraZeneca, Bayer, Sanofi, Dexcom
OpenAlex ID: W2403039904
